Dr. Rose is an accomplished serial entrepreneur and focuses on Healthcare companies in his work with Point Judith. Currently, he is a Director of Cellular Dynamics International (Madison, WI), the world's largest producer of fully functional human cells derived from induced pluripotent stem cells (iPS cells). He is also a Director of Inverna (Madison, WI), an early stage company developing novel technology for peptide drug discovery. Additionally, Dr. Rose is a Member of Tactics II SC Management LLC (Madison, WI), an investment fund focused on companies in the stem cell space. He is also a board Director and the Chief Commercial Officer of Nabsys, a Point Judith portfolio company. Prior to Nabsys, Dr. Rose served as President of Roche NimbleGen.
Previously, he was CEO of NimbleGen Systems, a microarray company that was sold to Roche for $272.5 million. Prior to NimbleGen, Dr. Rose co-founded Genetic MicroSystems, a microarray instruments company that was acquired by Affymetrix for $280 million. He also led the polymerase chain reaction (PCR) business for Perkin-Elmer during its most dynamic growth phase, both before and after the PCR business was acquired by Hoffman LaRoche. He was involved in the team that negotiated the acquisition of Applied Biosystems by Perkin-Elmer which created one of the world’s leading healthcare research products companies.
Dr. Rose received his B.A. from Cornell University and his Ph.D. from the Massachusetts Institute of Technology.